僑雄國際(00381.HK)擬向俄羅斯北極星發行1億元承兌票據
僑雄國際(00381.HK)公布,擬將向俄羅斯北極星發行金額1億元五年期承兌票據作為合同項下可退還保證金,該保證金將託管於律師事務所。該金額1億港元之5年期承兌票據尚未發行,且僅將公司信納完成相關移交手續,以令有效授權公司有權按合同管理及營運俄羅斯北極星合同資產後方會發行。
公司同時宣布,即將於俄羅斯成立一間全資附屬公司,並計劃投入5,000萬元作為項目的啟動資金。據董事作出一切合理查詢後所知、所悉及所信,已有32億元投入項目,及項目可利用的林地為300萬公頃。為實現公司在合約完成後能達到預期的回報,集團已就項目第一階段的管理及營運分別僱用陳嘉寧及儲浩然為項目總監及項目顧問。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.